COR vs HWKN
COR: Cencora is a critical link in the global healthcare supply chain, providing pharmaceutical distribution, commercialization services, and specialty drug support to ensure patients have access to life-saving medications. HWKN: Hawkins is a specialty chemical company providing critical water treatment solutions, food and pharmaceutical ingredients, and industrial chemical processing services.
Side-by-side fundamentals
| Metric | COR | HWKN | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $311.15 | $135.29 | |
| Market cap as of 2026-08-06 | $60.5B | $2.8B | |
| P/E as of 2026-08-06 | 24.22 | 35.01 | COR lower |
| PEG as of 2026-08-06 | 2.26 | n/a | |
| Net margin as of 2026-08-06 | +0.8% | +7.3% | HWKN higher |
| Gross margin as of 2026-08-06 | +3.8% | +22.3% | HWKN higher |
| Operating margin as of 2026-08-06 | +0.8% | +10.7% | HWKN higher |
| ROE as of 2026-08-06 | +115.9% | +15.3% | COR higher |
| ROA as of 2026-08-06 | +3.3% | +8.2% | HWKN higher |
| Debt / equity as of 2026-08-06 | 3.65 | 0.45 | HWKN lower |
| Revenue growth (YoY) as of 2026-08-06 | +6.0% | +9.3% | HWKN higher |
| Revenue CAGR (3y) SEC XBRL | +10.4% | +5.0% | COR higher |
| Dividend yield as of 2026-08-06 | +0.8% | +0.6% | COR higher |
| Dividend streak (yrs) SEC XBRL | 4 | 5 | HWKN higher |
| Beta as of 2026-08-06 | 0.57 | 0.76 | |
| 1-year return as of 2026-07-27 close | +7.2% | -19.9% | COR higher |
Fundamentals: market data, as of 2026-08-06. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.